Literature DB >> 23219169

Prevalence of indolent systemic mastocytosis in a Dutch region.

Jasper J van Doormaal, Suzanne Arends, Kim L Brunekreeft, V Bauco van der Wal, Johanna Sietsma, Pieter C van Voorst Vader, Joanne N G Oude Elberink, Johanna C Kluin-Nelemans, Eveline van der Veer, Jan G R de Monchy.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23219169     DOI： 10.1016/j.jaci.2012.10.015

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  21 in total

Review 1.  Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association.

Authors:  Patrizia Bonadonna; Massimiliano Bonifacio; Carla Lombardo; Roberta Zanotti
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

2.  Clinical and Molecular Diagnostic Evaluation of Systemic Mastocytosis in the South-Eastern Hungarian Population Between 2001-2013--A Single Centre Experience.

Authors:  Imelda Marton; László Krenács; Enikő Bagdi; Annamária Bakos; Judit Demeter; Zita Borbényi
Journal:  Pathol Oncol Res       Date:  2015-11-06       Impact factor: 3.201

3.  Determination of plasma heparin level improves identification of systemic mast cell activation disease.

Authors:  Milda Vysniauskaite; Hans-Jörg Hertfelder; Johannes Oldenburg; Peter Dreßen; Stefan Brettner; Jürgen Homann; Gerhard J Molderings
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

Review 4.  Critical care management of systemic mastocytosis: when every wasp is a killer bee.

Authors:  Hinke Y van der Weide; David J van Westerloo; Walter M van den Bergh
Journal:  Crit Care       Date:  2015-06-03       Impact factor: 9.097

Review 5.  Mast cell-mediated and associated disorders in pregnancy: a risky game with an uncertain outcome?

Authors:  Katja Woidacki; Ana Claudia Zenclussen; Frank Siebenhaar
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

6.  The Role of TRAF4 and B3GAT1 Gene Expression in the Food Hypersensitivity and Insect Venom Allergy in Mastocytosis.

Authors:  Aleksandra Górska; Marta Gruchała-Niedoszytko; Marek Niedoszytko; Agnieszka Maciejewska; Marta Chełmińska; Marcin Skrzypski; Bartosz Wasąg; Małgorzata Kaczkan; Magdalena Lange; Bogusław Nedoszytko; Ryszard Pawłowski; Sylwia Małgorzewicz; Ewa Jassem
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2016-04-16       Impact factor: 4.291

7.  Risk of solid cancer in patients with mast cell activation syndrome: Results from Germany and USA.

Authors:  Gerhard J Molderings; Thomas Zienkiewicz; Jürgen Homann; Markus Menzen; Lawrence B Afrin
Journal:  F1000Res       Date:  2017-10-26

8.  Efficacy of Omalizumab in Indolent Systemic Mastocytosis.

Authors:  Calum Slapnicar; Martina Trinkaus; Lisa Hicks; Peter Vadas
Journal:  Case Rep Hematol       Date:  2019-09-16

Review 9.  Pharmacological treatment options for mast cell activation disease.

Authors:  Gerhard J Molderings; Britta Haenisch; Stefan Brettner; Jürgen Homann; Markus Menzen; Franz Ludwig Dumoulin; Jens Panse; Joseph Butterfield; Lawrence B Afrin
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-30       Impact factor: 3.000

10.  Pregnancy and Delivery in Patients with Mastocytosis Treated at the Polish Center of the European Competence Network on Mastocytosis (ECNM).

Authors:  Katarzyna Ciach; Marek Niedoszytko; Anna Abacjew-Chmylko; Izabela Pabin; Przemyslaw Adamski; Katarzyna Leszczynska; Krzysztof Preis; Hanna Olszewska; Dariusz G Wydra; Rita Hansdorfer-Korzon
Journal:  PLoS One       Date:  2016-01-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.